Skip to navigation Skip to content
  • Chinese (Simplified)
  • English
ERS Genomics
  • CRISPR/Cas9
  • Intellectual Property
  • Licensing
  • Express License
  • Learn
    • What is CRISPR/Cas9
    • Knowledge Center
    • Downloads
  • Press Releases
  • Our Team
  • Contact Us

Press Releases

A Year Since BIO
Press Release
A Year Since BIO
Posted on11 June 202511 June 2025
CVC successfully appeals prior CRISPR U.S. patent decision
Press Release
CVC successfully appeals prior CRISPR U.S. patent decision
Posted on15 May 202515 May 2025
AI + CRISPR: Powering the 21st Century’s Biological Revolution 
Press Release
AI + CRISPR: Powering the 21st Century’s Biological Revolution 
Posted on22 April 202522 April 2025
ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement 
Press Release
ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement 
Posted on27 March 202527 March 2025
European Patent Office Grants CVC Portfolio Key CRISPR Patent
Press Release
European Patent Office Grants CVC Portfolio Key CRISPR Patent
Posted on26 February 202526 February 2025
Annual Letter From The CEO
Press Release
Annual Letter From The CEO
Posted on28 January 202528 January 2025
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9 
Press Release
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9 
Posted on13 January 202513 January 2025
A Letter from the CEO
Article
A Letter from the CEO
Posted on30 October 202428 January 2025
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Posted on30 September 202430 September 2024
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Posted on4 September 20244 September 2024
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Posted on20 May 202420 June 2024
ERS Genomics appoints John E Milad as Chief Executive Officer
Press Release
ERS Genomics appoints John E Milad as Chief Executive Officer
Posted on13 May 202413 May 2024
Update: Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration
Press Release
Update: Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration
Posted on1 May 202413 May 2024
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Press Release
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Posted on13 March 202413 May 2024
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
Posted on17 January 202413 May 2024
Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office
Press Release
Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office
Posted on13 December 202313 May 2024
New CRISPR/Cas9 Licensing Agreement for ERS Genomics & CHUM Research Centre, Montreal
Press Release
New CRISPR/Cas9 Licensing Agreement for ERS Genomics & CHUM Research Centre, Montreal
Posted on26 October 202313 May 2024
ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International
Press Release
ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International
Posted on19 October 202313 May 2024
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Posted on14 September 202314 September 2023
ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement
Posted on5 September 20235 September 2023

ERS Genomics

Wework
5 Harcourt Road
Dublin 2
D02 FW64

Privacy Policy | Cookies policy

  • CRISPR/Cas9
  • Intellectual Property
  • Licensing
  • Express License
  • Learn
    • What is CRISPR/Cas9
    • Knowledge Center
    • Downloads
  • Press Releases
  • Our Team
  • Contact Us

© 2021 ERS Genomics

Website by Egg

[ Placeholder content for popup link ] WordPress Download Manager - Best Download Management Plugin